Adjunctive pharmaceutical management is also necessary, as the gastric remnant often continues to secrete gastrin after RYGB; thus, patients are often prescribed lifelong proton pump inhibitor (PPI) medication to reduce the occurrence of peptic ulcers [8]. This evidence concerns the gene GAST and peptic ulcer disease.